GE HealthCare Technologies
GEHC
64.67
-0.10
-0.15%
GE HealthCare Technologies
US · GEHC
#689 by market cap
Listed 2022
64.67
-0.10
-0.15%
Live - 5344 symbols - heartbeat 131s ago
· 2026-10-08 06:39
Pre-market
64.40
-0.42%
After-hours
64.67
0.00%
Overnight
64.55
-0.19%
- Market cap
- 29.21B
- P/E (TTM)i
- 14.90
- P/Bi
- 2.66
- EPSi
- 4.55
- Div yieldi
- 0.22%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on GEHC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 7 in the most recent period (2026/Q3).
- Total institutional ownership rose 2.0 percentage points.
Institutional ownership
- Held by institutions
- 93.79% +2.04pp
- Institutions
- 1,466 -7
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund80.65%
Public Company3.55%
Hedge Fund3.18%
Government Pension Fund1.98%
Private Company1.55%
Sovereign Wealth Fund1.32%
VC/PE Fund0.80%
Family Office/Trust0.24%
Individual/Insider0.22%
Other6.51%
Top holders as of 2026-07-31
Dodge & Cox
10.48% · 47.33M sh
BlackRock
8.30% · 37.47M sh
Vanguard Capital Management, LLC
7.15% · 32.28M sh
State Street Global Advisors
4.62% · 20.86M sh
Vanguard Portfolio Management, LLC
4.49% · 20.28M sh
Invesco Capital Management LLC
3.52% · 15.91M sh
Harris Associates L.P.
3.39% · 15.33M sh
Barrow, Hanley, Mewhinney & Strauss, LLC
2.98% · 13.46M sh
Geode Capital Management, LLC
2.85% · 12.87M sh
Hotchkis and Wiley Capital Management, LLC
2.71% · 12.25M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| H. Culp | Chairperson | 0.11% |
| Peter Arduini | Chief Executive Officer | 0.03% |
| Frank Jimenez | General Counsel | 0.02% |
| Taha Kass-Hout | Chief Technology Officer | 0.01% |
| James Saccaro | Vice President | 0.01% |
| Kevin O’Neill | CEO of Pharmaceutical Diagnostics | 0.00% |
| Kenneth Stacherski | Chief Global Supply Chain & Service Officer | 0.00% |
| Anne Madden | Independent Director | 0.00% |
| Roland Rott | CEO of Ultrasound | 0.00% |
| Catherine Estrampes | President and CEO of US & Canada | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-13 | William Grogan | Chief Financial Officer | Other Acquisition | +75,096 | -- |
| 2026-09-13 | William Grogan | Chief Financial Officer | Other Derivative Acquisition | +31,877 | $64.25 |
| 2026-09-02 | Peter Arduini | Chief Executive Officer | Sale to Issuer | -6,303 | $70.56 |
| 2026-09-02 | George Newcomb | Controller & Chief Accounting Officer | Sale to Issuer | -112 | $70.56 |
| 2026-09-02 | Frank Jimenez | General Counsel | Sale to Issuer | -1,480 | $70.56 |
| 2026-09-02 | Adam Holton | Chief Human Resources Officer | Sale to Issuer | -673 | $70.56 |
| 2026-09-02 | Catherine Estrampes | President and CEO of US & Canada | Sale to Issuer | -508 | $70.56 |
| 2026-09-02 | Philip Rackliffe | President & CEO of Image Guided Therapies & Ultrasound | Sale to Issuer | -798 | $70.56 |
| 2026-09-02 | Kevin O’Neill | CEO of Pharmaceutical Diagnostics | Sale to Issuer | -718 | $70.56 |
| 2026-09-02 | Taha Kass-Hout | Chief Technology Officer | Sale to Issuer | -1,502 | $70.56 |
| 2026-08-31 | Peter Arduini | Chief Executive Officer | Sale to Issuer | -11,515 | $71.23 |
| 2026-08-31 | Frank Jimenez | General Counsel | Sale to Issuer | -3,131 | $71.23 |
| 2026-08-31 | Adam Holton | Chief Human Resources Officer | Sale to Issuer | -659 | $71.23 |
| 2026-08-31 | Jeannette Bankes | President & CEO of Patient Care Solutions | Sale to Issuer | -1,064 | $71.23 |
| 2026-08-31 | Philip Rackliffe | President & CEO of Image Guided Therapies & Ultrasound | Sale to Issuer | -856 | $71.23 |
| 2026-08-31 | Taha Kass-Hout | Chief Technology Officer | Sale to Issuer | -2,940 | $71.23 |
| 2026-08-14 | Adam Holton | Chief Human Resources Officer | Sale to Issuer | -1,360 | $73.69 |
| 2026-05-21 | Kevin Lobo | Director | Open Market Acquisition | +10,000 | $64.18 |
| 2026-05-14 | Jeannette Bankes | President & CEO of Patient Care Solutions | Sale to Issuer | -5,535 | $62.67 |
| 2026-05-14 | Philip Rackliffe | President & CEO of Image Guided Therapies & Ultrasound | Other Acquisition | +16,458 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:39:23 · For reference only, not investment advice and not tailored to your situation.